Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 269 of the 291 references it cites were found in a registry or an index.

ACG Clinical Guideline: Management of Irritable Bowel Syndrome

Abstract

Irritable bowel syndrome (IBS) is a highly prevalent, chronic disorder that significantly reduces patients' quality of life. Advances in diagnostic testing and in therapeutic options for patients with IBS led to the development of this first-ever American College of Gastroenterology clinical guideline for the management of IBS using Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology. Twenty-five clinically important questions were assessed after a comprehensive literature search; 9 questions focused on diagnostic testing; 16 questions focused on therapeutic options. Consensus was obtained using a modified Delphi approach, and based on GRADE methodology, we endorse the following: We suggest that a positive diagnostic strategy as compared to a diagnostic strategy of exclusion be used to improve time to initiating appropriate therapy. We suggest that serologic testing be performed to rule out celiac disease in patients with IBS and diarrhea symptoms. We suggest that fecal calprotectin be checked in patients with suspected IBS and diarrhea symptoms to rule out inflammatory bowel disease. We recommend a limited trial of a low fermentable oligosaccharides, disacchardies, monosaccharides, polyols (FODMAP) diet in patients with IBS to improve global symptoms. We recommend the use of chloride channel activators and guanylate cyclase activators to treat global IBS with constipation symptoms. We recommend the use of rifaximin to treat global IBS with diarrhea symptoms. We suggest that gut-directed psychotherapy be used to treat global IBS symptoms. Additional statements and information regarding diagnostic strategies, specific drugs, doses, and duration of therapy can be found in the guideline.

Overview

Integrity signals

Registry

Crossref · 10.14309/ajg.0000000000001036

Cites

269 of 269 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 291 references

Research works printed but not linked: 6

  1. 2016, Fed Regist, 81, 33581
  2. Carling, 1989, Short term treatment of irritable bowel syndrome: A placebo-controlled trial of peppermint oil against hyoscyamine, OPMEAR, 34, 55
  3. 2008, FDA approves lubiprostone (Amitiza) for women with IBS with constipation, Medpage Today
  4. Boerner, 1988, Wirksamkeit und vertraglichkeit eines antidepressivuns beim colon irritabile, Therapiewoche, 38, 201
  5. Vij, 1991, Effect of antidepressant drug (doxepin) on irritable bowel syndrome patients, Indian J Psychiatry, 33, 243
  6. Bergmann, 1991, [Die therapie des colon irritabile mit trimipramin (Herphonal): Eine kontrollierte studie], Z Klin Med, 46, 1621

Cited by

See all 893

Metadata

Authors
Lacy, B. E., Pimentel, M., Brenner, D. M., Chey, W. D., Keefer, L. A., Long, M. D., & Moshiree, B.
Affiliations
  • Mayo Clinic (US)
  • Cedars-Sinai Medical Center (US)
  • Northwestern University (US)
  • University of Michigan (US)
  • Icahn School of Medicine at Mount Sinai (US)
  • University of North Carolina at Chapel Hill (US)
  • University of North Carolina at Charlotte (US)
Corresponding author
Lacy, Brian E.
Venue
American Journal of Gastroenterology
Published
2020-12-14
Volume
116
Issue
1
Pages
17-44
ISSN
  • 0002-9270 (ISSN-L)
  • 1572-0241
OpenAlex
W3112460492
Cited by
893
References
291
Citations by year
2026: 197 · 2025: 146 · 2024: 175 · 2023: 148 · 2022: 138 · 2021: 88
FWCI
81.22
Type
journal article
Language
en
Open access
closed
Locations
  • The American Journal of Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Infant Health and Development
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
irritable bowel syndrome, IBS management, IBS diagnosis, diagnostic testing, celiac disease screening, fecal calprotectin, inflammatory bowel disease exclusion, FODMAP diet, chloride channel activator, rifaximin, irritable bowel syndrome with constipation, diarrhea-predominant irritable bowel syndrome
MeSH terms
Guanylyl Cyclase C Agonists, Rifaximin, Celiac Disease, Constipation, Delphi Technique, Diagnosis, Differential, Diarrhea, Diet Therapy, Feces, Gastroenterology, Gastrointestinal Agents, Humans, Hypnosis, Serologic Tests, Societies, Medical, Inflammatory Bowel Diseases, Cognitive Behavioral Therapy, Disease Management, Leukocyte L1 Antigen Complex, Irritable Bowel Syndrome, Chloride Channel Agonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ACG Clinical Guideline: Management of Irritable Bowel Syndrome. https://app.cochat.ai/papers/10.14309/ajg.0000000000001036
The paper
Lacy, B. E., Pimentel, M., Brenner, D. M., Chey, W. D., Keefer, L. A., Long, M. D., & Moshiree, B. (2021). ACG Clinical Guideline: Management of Irritable Bowel Syndrome. American Journal of Gastroenterology. https://doi.org/10.14309/ajg.0000000000001036

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.